{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:33:00Z","timestamp":1762101180204},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T00:00:00Z","timestamp":1302566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s11916-011-0199-x","type":"journal-article","created":{"date-parts":[[2011,5,2]],"date-time":"2011-05-02T04:09:45Z","timestamp":1304309385000},"page":"164-169","source":"Crossref","is-referenced-by-count":12,"title":["Are Antiepileptic Drugs Used in the Treatment of Migraine Associated with an Increased Risk of Suicidality?"],"prefix":"10.1007","volume":"15","author":[{"given":"Andres M.","family":"Kanner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,12]]},"reference":[{"key":"199_CR1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1526-4610.2007.00993.x","volume":"48","author":"N Jette","year":"2008","unstructured":"\u2022 Jette N, Patten S, Williams J, et al. Comorbidity of migraine and psychiatric disorders--a national population-based study. Headache. 2008;48:501\u2013516. This is an important reference that illustrates the high prevalence of psychiatric comorbidities in the general population of patients who suffer from migraine.","journal-title":"Headache"},{"key":"199_CR2","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1212\/01.WNL.0000058907.41080.54","volume":"60","author":"N Breslau","year":"2003","unstructured":"Breslau N, Lipton RB, Stewart WF, et al. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology. 2003;60:1308\u201312.","journal-title":"Neurology"},{"key":"199_CR3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archneur.65.6.709","volume":"65","author":"MA Rogawski","year":"2008","unstructured":"\u2022 Rogawski MA. Common pathophysiologic mechanisms in migraine and epilepsy. Arch Neurol. 2008;65:709\u201314. This review paper provides a comprehensive review of the pathogenic mechanisms operant in migraine and epilepsy and explain the rationale for the use of antiepileptic drugs in the prophylactic treatment of migraines.","journal-title":"Arch Neurol"},{"issue":"291","key":"199_CR4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.291.8.965","volume":"25","author":"JL Brandes","year":"2004","unstructured":"Brandes JL, Saper JR, Diamond M, et al. MIGR-002 Study Group. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;25(291):965\u201373.","journal-title":"JAMA"},{"key":"199_CR5","first-page":"19","volume":"41","author":"NT Mathew","year":"2001","unstructured":"Mathew NT, Rapoport A, Saper J, et al. Efficacy of gabapentin in migraine prophylaxis. Headache. 2001;41:19\u2013128.","journal-title":"Headache"},{"key":"199_CR6","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/WNL.58.11.1652","volume":"58","author":"FG Freitag","year":"2002","unstructured":"Freitag FG, Collins SD, Carlson HA, et al. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology. 2002;58:1652\u20139.","journal-title":"Neurology"},{"key":"199_CR7","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Biostatistics (2008). Statistical review and evaluation: Antiepileptic drugs and suicidality. May 21, 2008."},{"key":"199_CR8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.56.7.617","volume":"56","author":"RD Kessler","year":"1999","unstructured":"Kessler RD, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry. 1999;56:617\u201326.","journal-title":"Arch Gen Psychiatry"},{"key":"199_CR9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1192\/bjp.bp.108.054049","volume":"194","author":"Z Saaman","year":"2009","unstructured":"Saaman Z, Farmer A, Craddock N, et al. Migraine in recurrent depression: case-control study. Br J Psychiatry. 2009;194:350\u20134.","journal-title":"Br J Psychiatry"},{"key":"199_CR10","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1046\/j.1468-2982.2001.00279.x","volume":"21","author":"OB Fasmer","year":"2001","unstructured":"Fasmer OB. The prevalence of migraine in patients with bipolar and unipolar affective disorders. Cephalalgia. 2001;21:894\u20135.","journal-title":"Cephalalgia"},{"key":"199_CR11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1212\/WNL.56.3.350","volume":"56","author":"N Breslau","year":"2001","unstructured":"Breslau N, Schultz LR, Stewart WF, et al. Headache types and panic disorder: directionality and specificity. Neurology. 2001;56:350\u20134.","journal-title":"Neurology"},{"key":"199_CR12","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1212\/01.WNL.0000058907.41080.54","volume":"60","author":"N Breslau","year":"2003","unstructured":"Breslau N, Lipton RB, Stewart WF, et al. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology. 2003;60:1308\u201312.","journal-title":"Neurology"},{"key":"199_CR13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0165-1781(91)90102-U","volume":"37","author":"N Breslau","year":"1991","unstructured":"Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res. 1991;37:11\u201323.","journal-title":"Psychiatry Res"},{"key":"199_CR14","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1212\/01.wnl.0000260607.90634.d6","volume":"68","author":"SJ Wang","year":"2007","unstructured":"Wang SJ, Juang KD, Fuh JL, et al. Psychiatric comorbidity and suicide risk in adolescents with chronic daily headache. Neurology. 2007;68:1468\u201373.","journal-title":"Neurology"},{"key":"199_CR15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/0333102410385581","volume":"31","author":"G Demarquay","year":"2011","unstructured":"\u2022\u2022 Demarquay G, Lothe A, Royet JP, Costes N, Mick G, Maugui\u00e8re F, Ryvlin P. Brainstem changes in 5-HT1A receptor availability during migraine attack. Cephalalgia. 2011;31:84\u201394. This is a state-of-the-art study that demonstrates the pathogenic role of serotonin in migraine.","journal-title":"Cephalalgia"},{"issue":"6 Suppl 3","key":"199_CR16","first-page":"S43","volume":"43","author":"MD Ferrari","year":"1993","unstructured":"Ferrari MD. Sumatriptan in the treatment of migraine. Neurology. 1993;43(6 Suppl 3):S43\u20137.","journal-title":"Neurology"},{"key":"199_CR17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archpsyc.57.2.174","volume":"57","author":"PA Sargent","year":"2000","unstructured":"Sargent PA, Kjaer KH, Bench CJ, et al. Brain serotonin 1A receptor binding measured by positron emission tomography with [11\u00a0C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry. 2000;57:174\u201380.","journal-title":"Arch Gen Psychiatry"},{"key":"199_CR18","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0006-3223(99)00189-4","volume":"46","author":"WC Drevets","year":"1999","unstructured":"Drevets WC, Frank E, Price JC, et al. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry. 1999;46:1375\u201387.","journal-title":"Biol Psychiatry"},{"key":"199_CR19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1523\/JNEUROSCI.4921-03.2004","volume":"24","author":"A Neumeister","year":"2004","unstructured":"Neumeister A, Bain E, Nugent AC, et al. Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci. 2004;24:589\u201391.","journal-title":"J Neurosci"},{"key":"199_CR20","first-page":"87","volume":"39","author":"M Asberg","year":"1984","unstructured":"Asberg M, Bertilsson L, Martensson B. Indolamine metabolites, depression and suicide. Adv Biochem Psychopharmacol. 1984;39:87\u201397.","journal-title":"Adv Biochem Psychopharmacol"},{"key":"199_CR21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-2007-979587","volume":"28","author":"D Lester","year":"1995","unstructured":"Lester D. The concentrations of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry. 1995;28:45\u201350.","journal-title":"Pharmacopsychiatry"},{"key":"199_CR22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1001\/archpsyc.60.1.14","volume":"60","author":"MA Oquendo","year":"2003","unstructured":"Oquendo MA, Placidi GP, Malone KM, et al. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry. 2003;60:14\u201322.","journal-title":"Arch Gen Psychiatry"},{"key":"199_CR23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0006-8993(95)00523-S","volume":"688","author":"V Arango","year":"1995","unstructured":"Arango V, Underwood MD, Gubbi AV, Mann JJ. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 1995;688:121\u201333.","journal-title":"Brain Res"},{"issue":"5","key":"199_CR24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3956(03)00048-7","volume":"37","author":"V Arango","year":"2003","unstructured":"Arango V, Huang YY, Underwood MD, Mann JJ. Genetics of the serotonergic system in suicidal behavior. J Psychiatr Res. 2003;37(5):375\u201386.","journal-title":"J Psychiatr Res"},{"key":"199_CR25","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/archpsyc.62.11.1249","volume":"62","author":"J Sareen","year":"2005","unstructured":"Sareen J, Cox BJ, Afifi TO, et al. Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults. Arch Gen Psychiatry. 2005;62:1249\u201357.","journal-title":"Arch Gen Psychiatry"},{"key":"199_CR26","first-page":"909","volume":"80","author":"DA Brent","year":"1987","unstructured":"Brent DA, Crumrine PK, Varma RR, Allan M, Allman C. Phenobarbital treatment and major depressive disorder in children with epilepsy. Pediatrics. 1987;80:909\u201317.","journal-title":"Pediatrics"},{"key":"199_CR27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/seiz.2000.0405","volume":"9","author":"RM Trimble","year":"2000","unstructured":"Trimble RM, R\u03cbsch N, Betts T, Crawford PM. Psychiatric symptoms after therapy with new antiepileptic drugs: Psychopathological and seizure related variables. Seizure. 2000;9:249\u201354.","journal-title":"Seizure"},{"key":"199_CR28","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1528-1157.2003.05402.x","volume":"44","author":"M Mula","year":"2003","unstructured":"Mula M, Trimble MR, Lhatoo SD, Sander JW. Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia. 2003;44:659\u201363.","journal-title":"Epilepsia"},{"key":"199_CR29","first-page":"704","volume":"61","author":"M Mula","year":"2007","unstructured":"Mula M, Trimble MR, Yuen A, Liu RS, Sander JW. Psychiatric adverse events during levetiracetam therapy. Epilepsia. 2007;61:704\u20136.","journal-title":"Epilepsia"},{"key":"199_CR30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yebeh.2007.04.008","volume":"11","author":"M Mula","year":"2007","unstructured":"Mula M, Sander JW. Suicidal ideation in epilepsy and levetiracetam therapy. Epilepsy Behav. 2007;11:130\u20132.","journal-title":"Epilepsy Behav"},{"key":"199_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1744-859X-10-1","volume":"18;10","author":"L Redden","year":"2011","unstructured":"Redden L, Pritchett Y, Robieson W, Kovacs X, Garofalo M, Tracy K, et al. Suicidality and divalproex sodium: analysis of controlled studies in multiple indications. Ann Gen Psychiatry. 2011;18;10:1.","journal-title":"Ann Gen Psychiatry"},{"key":"199_CR32","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/pds.2036","volume":"19","author":"RD Gibbons","year":"2010","unstructured":"Gibbons RD, Hur K, Brown CH, Mann JJ. Gabapentin and suicide attempts. Pharmacoepidemiol Drug Saf. 2010;19:1241\u20137.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"199_CR33","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1528-1167.2009.02012.x","volume":"50","author":"DC Hesdorffer","year":"2009","unstructured":"\u2022 Hesdorffer DC and Kanner AM. The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm? Epilepsia. 2009;50:978\u201386. This article provides a critical assessment of the FDA meta-analysis and points out methodological problems that question the conclusion that all AEDs can increase the risk of suicidality.","journal-title":"Epilepsia"},{"key":"199_CR34","unstructured":"GlaxoSmithKline (2006) Briefing Document: Paroxetine Adult Suicidality Analysis: Major Depressive Disorder and non-Major Depressive Disorder. Available at: ( http:\/\/www.gsk.com\/media\/par_current_analysis.htm ) [Accessed April 5, 2006]."},{"key":"199_CR35","unstructured":"Dr. Katz memo and briefing document to PCNS and PD Advisory Committees (2008) Briefing document for the July 10, 2008 Advisory Committees to discuss antiepileptic drugs (AEDs) and suicidality. Available at: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/08\/briefing\/2008-4372b1-01-FDA-Katz.pdf ."},{"key":"199_CR36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2307\/2530643","volume":"41","author":"S Greenland","year":"1985","unstructured":"Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics. 1985;41:55\u201368.","journal-title":"Biometrics"},{"key":"199_CR37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1212\/WNL.64.11.1834","volume":"64","author":"JA French","year":"2005","unstructured":"French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2005;64:172\u20134.","journal-title":"Neurology"},{"key":"199_CR38","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/archgenpsychiatry.2009.159","volume":"66","author":"RD Gibbons","year":"2009","unstructured":"Gibbons RD, Jur K, Brown CH, Mann JJ. Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry. 2009;66:1354\u201360.","journal-title":"Arch Gen Psychiatry"},{"key":"199_CR39","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/pds.1932","volume":"19","author":"JB Olesen","year":"2010","unstructured":"Olesen JB, Hansen PR, Erdal J, et al. Antiepileptic drugs and risk of suicide: a nationwide study. Pharmacoepidemiol Drug Saf. 2010;19:518\u201324.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"199_CR40","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.2010.410","volume":"303","author":"E Patorno","year":"2010","unstructured":"Patorno E, Bohn RL, Wahl PM, Avorn J, Patrick AR, Liu J, et al. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA. 2010;303:1401\u20139.","journal-title":"JAMA"},{"key":"199_CR41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1741-7015-8-4","volume":"8","author":"AC VanCott","year":"2010","unstructured":"VanCott AC, Cramer JA, Copeland LA, Zeber JE, Steinman MA, Dersh JJ, et al. Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VS hospital system. BMC Med. 2010;8:4.","journal-title":"BMC Med"},{"key":"199_CR42","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMoa0909801","volume":"363","author":"A Arana","year":"2010","unstructured":"Arana A, Wentworth CE, Ayuso-Mateos JL, Arellano FM. Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med. 2010;363:542\u201351.","journal-title":"N Engl J Med"},{"key":"199_CR43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1535-7511.2010.01382.x","volume":"10","author":"DC Hesdorffer","year":"2010","unstructured":"Hesdorffer DC, Berg AT, Kanner AM. An update on antiepileptic drugs and suicide: are there definitive answers yet? Epilepsy Curr. 2010;10:137\u201345.","journal-title":"Epilepsy Curr"},{"key":"199_CR44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"199_CR45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0272-7358(88)90050-5","volume":"8","author":"AT Beck","year":"1988","unstructured":"Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77\u2013100.","journal-title":"Clin Psychol Rev"},{"key":"199_CR46","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","volume":"56","author":"AT Beck","year":"1988","unstructured":"Beck AT, Brown G, Epstein N, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893\u20137.","journal-title":"J Consult Clin Psychol"},{"issue":"Suppl 20","key":"199_CR47","first-page":"22","volume":"59","author":"BV Sheehan","year":"1998","unstructured":"Sheehan BV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini International Neuropsychiatric Interview (MINI): the development and validation of structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22\u201333.","journal-title":"J Clin Psychiatry"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-011-0199-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-011-0199-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-011-0199-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T12:18:04Z","timestamp":1637583484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-011-0199-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,12]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["199"],"URL":"https:\/\/doi.org\/10.1007\/s11916-011-0199-x","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,12]]}}}